Title:
POROUS CELLULAR SCAFFOLD COMPRISING SERUM-DERIVED PROTEIN, AND PRODUCTION METHOD THEREFOR
Document Type and Number:
WIPO Patent Application WO/2020/222414
Kind Code:
A1
Abstract:
The present invention relates to a porous cellular scaffold comprising a serum-derived protein, and a production method therefor. The porous cellular scaffold, according to one embodiment, not only enables cells to be stably and continuously cultured, but also enables mimicking actual tissue by exhibiting an aspect of culturing, for each cell, that matches the characteristics of the cell, and enables stable culturing and high in vivo engraftment, and thus has an effect of being capable of being usefully employed in organoid-utilizing drug activity and toxicity assessments, cellular therapy products or target protein production.
More Like This:
Inventors:
JU SEUNG YON (KR)
Application Number:
PCT/KR2020/002919
Publication Date:
November 05, 2020
Filing Date:
February 28, 2020
Export Citation:
Assignee:
DANAGREEN CO LTD (KR)
International Classes:
C12N5/00; C12N5/077; C12N5/09
Foreign References:
| US20140213765A1 | 2014-07-31 | |||
| US20100184183A1 | 2010-07-22 | |||
| KR20180089144A | 2018-08-08 | |||
| KR20180011656A | 2018-02-02 |
Other References:
YOON, DAEYOUNG: "Effect of serum-derived albumin scaffold and canine adipose tissue-derived mesenchymal stem cells on osteogenesis in canine segmental bone defect model", J. VET. SCI., vol. 16, no. 4, 2015, pages 397 - 404, XP055756403
"Remington's Pharmaceutical Sciences", 1995
See also references of EP 3916080A4
"Remington's Pharmaceutical Sciences", 1995
See also references of EP 3916080A4
Attorney, Agent or Firm:
Y.P.LEE, MOCK & PARTNERS (KR)
Download PDF: